Skip to main content
. Author manuscript; available in PMC: 2021 Jan 9.
Published in final edited form as: Org Biomol Chem. 2020 Sep 23;18(36):7110–7126. doi: 10.1039/d0ob01447h

Table 1.

Ratios between asymmetric and symmetric conformer in CD3OH and CDCl3 for compounds 1, 2 and 8. Literature values are given in parentheses. Ratio marked with * was reported in CD3OD

Compound Conformer ratio in CD3OH (asymmetric : symmetric) Conformer ratio in CDCl3 (asymmetric : symmetric)
PF1022A (1) 5 : 1–7 : 1a (4 : 1*9) 3 : 1 (3 : 138)
Emodepside (2) 7 : 1 7 : 2
Bis-aza analog (8) 12 : 1 10 : 1 (100 : 736)
a

The variability is likely due to residual cation content originating from synthesis, workup and purification that differs from batch to batch.